» Articles » PMID: 36775890

Built Environment Factors Predictive of Early Rapid Lung Function Decline in Cystic Fibrosis

Abstract

Background: The extent to which environmental exposures and community characteristics of the built environment collectively predict rapid lung function decline, during adolescence and early adulthood in cystic fibrosis (CF), has not been examined.

Objective: To identify built environment characteristics predictive of rapid CF lung function decline.

Methods: We performed a retrospective, single-center, longitudinal cohort study (n = 173 individuals with CF aged 6-20 years, 2012-2017). We used a stochastic model to predict lung function, measured as forced expiratory volume in 1 s (FEV ) of % predicted. Traditional demographic/clinical characteristics were evaluated as predictors. Built environmental predictors included exposure to elemental carbon attributable to traffic sources (ECAT), neighborhood material deprivation (poverty, education, housing, and healthcare access), greenspace near the home, and residential drivetime to the CF center.

Measurements And Main Results: The final model, which included ECAT, material deprivation index, and greenspace, alongside traditional demographic/clinical predictors, significantly improved fit and prediction, compared with only demographic/clinical predictors (Likelihood Ratio Test statistic: 26.78, p < 0.0001; the difference in Akaike Information Criterion: 15). An increase of 0.1 μg/m of ECAT was associated with 0.104% predicted/yr (95% confidence interval: 0.024, 0.183) more rapid decline. Although not statistically significant, material deprivation was similarly associated (0.1-unit increase corresponded to additional decline of 0.103% predicted/year [-0.113, 0.319]). High-risk regional areas of rapid decline and age-related heterogeneity were identified from prediction mapping.

Conclusion: Traffic-related air pollution exposure is an important predictor of rapid pulmonary decline that, coupled with community-level material deprivation and routinely collected demographic/clinical characteristics, enhance CF prognostication and enable personalized environmental health interventions.

Citing Articles

A New Frontier in Cystic Fibrosis Pathophysiology: How and When Clock Genes Can Affect the Inflammatory/Immune Response in a Genetic Disease Model.

Carbone A, Vitullo P, Di Gioia S, Castellani S, Conese M Curr Issues Mol Biol. 2024; 46(9):10396-10410.

PMID: 39329970 PMC: 11430433. DOI: 10.3390/cimb46090618.


Evaluating precision medicine tools in cystic fibrosis for racial and ethnic fairness.

Colegate S, Palipana A, Gecili E, Szczesniak R, Brokamp C J Clin Transl Sci. 2024; 8(1):e94.

PMID: 39220818 PMC: 11362628. DOI: 10.1017/cts.2024.532.


Robust identification of environmental exposures and community characteristics predictive of rapid lung disease progression.

Peterson C, Rao M, Palipana A, Manning E, Vancil A, Ryan P Sci Total Environ. 2024; 950:175348.

PMID: 39117222 PMC: 11349456. DOI: 10.1016/j.scitotenv.2024.175348.


Social-environmental phenotypes of rapid cystic fibrosis lung disease progression in adolescents and young adults living in the United States.

Palipana A, Vancil A, Gecili E, Rasnick E, Ehrlich D, Pestian T Environ Adv. 2023; 14.

PMID: 38094913 PMC: 10718514. DOI: 10.1016/j.envadv.2023.100449.

References
1.
Pfeffer P, Mudway I, Grigg J . Air Pollution and Asthma: Mechanisms of Harm and Considerations for Clinical Interventions. Chest. 2021; 159(4):1346-1355. DOI: 10.1016/j.chest.2020.10.053. View

2.
Szczesniak R, Li D, Su W, Brokamp C, Pestian J, Seid M . Phenotypes of Rapid Cystic Fibrosis Lung Disease Progression during Adolescence and Young Adulthood. Am J Respir Crit Care Med. 2017; 196(4):471-478. PMC: 5564675. DOI: 10.1164/rccm.201612-2574OC. View

3.
Roberts J, Wilcox P, Quon B . Evaluating Adult Cystic Fibrosis Care in BC: Disparities in Access to a Multidisciplinary Treatment Centre. Can Respir J. 2016; 2016:8901756. PMC: 4904545. DOI: 10.1155/2016/8901756. View

4.
Brunst K, Ryan P, Brokamp C, Bernstein D, Reponen T, Lockey J . Timing and Duration of Traffic-related Air Pollution Exposure and the Risk for Childhood Wheeze and Asthma. Am J Respir Crit Care Med. 2015; 192(4):421-7. PMC: 4595664. DOI: 10.1164/rccm.201407-1314OC. View

5.
Davies J, Moskowitz S, Brown C, Horsley A, Mall M, McKone E . VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles. N Engl J Med. 2018; 379(17):1599-1611. PMC: 6277022. DOI: 10.1056/NEJMoa1807119. View